Sign inJoin free

Watch / US Equities

Armina comes armed with these stock picks

4 May 202610:09

Armina comes armed with these stock picks

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key points:

  • Strong AI‑driven tilt to US equities and infrastructure layer

  • Nuanced view on software: workflow lock‑in and AI agent usage seen as critical

  • Memory oligopoly (SK Hynix, Samsung, Micron) viewed as major AI winner

  • Artrya highlighted as core Aussie exposure in AI‑enabled healthcare

Armin Rosenberg from Minotaur Capital sets out a strongly AI‑centric global equity view, with more than half of the portfolio allocated to the United States. Rosenberg sees the multi‑year AI infrastructure build by US hyperscalers as the key driver, arguing that current economics largely accrue to the infrastructure and memory layers rather than software. Alphabet, Microsoft and Nvidia remain core to the AI narrative, but Rosenberg notes that monetisation in software and cloud is still lagging usage metrics such as Gemini and Copilot adoption.

Rosenberg outlines a differentiated stance on software, having previously shorted names on fears that AI coding agents erode value where there is little workflow lock‑in. By contrast, Rosenberg views Atlassian (NASDAQ:TEAM) as a bellwether beneficiary, highlighting accelerating cloud revenue growth, rising seat counts and stronger usage of its Teamwork Collection. Communications and contact‑centre infrastructure names are seen as better positioned than workflow tools that rely purely on human input.

On AI hardware, Rosenberg is especially positive on memory, with significant exposure to SK Hynix, Micron Technology (NASDAQ:MU) and Samsung Electronics. European defence and precious metals positions have been more volatile, while Artrya (ASX:AYA) remains the largest Australian holding, reflecting conviction in AI‑enabled healthcare diagnostics.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy